Lancet Review Time
The Lancet's review timeline, where delays usually happen, and what the timing means if you are preparing to submit.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
What to do next
Already submitted to The Lancet? Use this page to interpret the status and choose the next step.
The useful next step is understanding what the status usually means at The Lancet, how long the wait normally runs, and when a follow-up is actually reasonable.
The Lancet is one of the fastest journals at desk rejection and one of the most deliberate at everything after. Over 80% of submissions are rejected without review, typically within 1-2 weeks. If you make it to peer review, the journal's concurrent statistical review and clinical scrutiny mean the process is thorough, not rushed.
Quick answer
Lancet's typical timeline: 1-2 weeks for desk decisions, 6-10 weeks from submission to first post-review decision for papers that enter review. Total time from submission to acceptance (including revision) typically runs 4-8 months. The journal is not trying to be fast. It's trying to be right.
Lancet review timeline at a glance
Stage | Typical timing | What is happening |
|---|---|---|
Initial screening | 2-5 days | Format check, basic scope assessment |
Editorial triage | 1-2 weeks | Senior editors assess clinical importance and global health relevance |
Statistical pre-review | Concurrent with peer review | In-house statisticians evaluate methodology |
Peer review | 4-6 weeks | 2-3 clinical reviewers assess evidence quality |
First decision | 6-10 weeks from submission | Accept, revise, or reject |
Revision window | 4-8 weeks typically | Must address both clinical and statistical reviewer concerns |
Post-revision review | 3-5 weeks | May return to original reviewers |
Acceptance to publication | Fast-tracked for urgent clinical findings, otherwise 2-4 weeks |
What makes the Lancet process different
In-house statistical review
The Lancet has in-house statisticians who review manuscripts during the editorial triage phase, not after peer review. This means statistical problems that would normally surface during revision are caught earlier. It also means the statistical bar is set by Lancet's own team, not by whatever statistician happens to be on the reviewer panel.
If your trial has methodological issues, the Lancet's process will find them faster than most journals.
The global health lens
Every paper is evaluated through a global health lens. The editors ask: does this change clinical practice in a way that matters to patients worldwide, not just in one healthcare system? Papers that are strong science but narrowly relevant to one country's clinical context may be redirected to a Lancet regional journal.
Concurrent review tracks
Peer review and statistical review run in parallel, not sequentially. This makes the first decision more definitive. When you get reviewer reports, they already incorporate statistical scrutiny. The revision is cleaner because the issues are comprehensive.
Common timeline patterns
Fast desk rejection (1-2 weeks): The paper didn't meet the clinical importance threshold. This is the most common outcome and not a reflection of scientific quality.
Sent to Lancet family journal (2-3 weeks): The editors see merit but not Lancet-level clinical importance. Lancet Oncology, Lancet Infectious Diseases, or a regional journal may be offered. This is worth considering seriously.
Review taking 6+ weeks: Normal. The concurrent statistical review adds time. Clinical reviewers are practicing physicians with patient responsibilities.
Revision with tight timeline: Lancet revisions often have shorter windows than other top journals. The expectation is that most issues can be addressed with existing data, since the study should be complete before submission.
When to follow up
Situation | What to do |
|---|---|
No desk decision after 3 weeks | Unusual. A polite inquiry is appropriate. |
Under review for 8+ weeks | Normal upper range. Wait. |
Under review for 12+ weeks | Follow up. Something may have stalled. |
Revision submitted, no response for 4+ weeks | Follow up. Post-revision should be faster. |
Should you submit to the Lancet?
Submit if:
- the clinical finding could change treatment guidelines or standard of care globally
- the trial design is methodologically rigorous with appropriate statistical power
- the study has global health relevance, not just relevance to one healthcare system
- the Research in Context panel writes itself (clear clinical implications)
Think twice if:
- the clinical importance is real but regional rather than global (consider Lancet regional journals)
- the paper is translational without direct clinical evidence (Nature Medicine may be better)
- the statistical design has known limitations you haven't addressed
- NEJM or JAMA would be a more natural editorial home for the clinical question
A free manuscript scan can help assess whether the clinical framing and statistical rigor meet Lancet expectations before submission.
FAQ
How long does the Lancet take to desk-reject?
Typically 1-2 weeks. Over 80% of submissions are desk-rejected.
How long does Lancet peer review take?
4-6 weeks for reviewer reports, 6-10 weeks total to first decision.
Does the Lancet have in-house statisticians?
Yes. Statistical review runs concurrently with peer review, which is unusual and raises the methodological bar.
What happens if the Lancet offers to transfer to a family journal?
Take it seriously. Lancet family journals (Oncology, Infectious Diseases, regional journals) are prestigious in their own right, and the transfer often includes the editor's recommendation.
Sources
- Clarivate Journal Citation Reports (released June 2025)
- The Lancet information for authors
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Best next step
Use this page to interpret the status and choose the next sensible move.
For The Lancet, the better next step is guidance on timing, follow-up, and what to do while the manuscript is still in the system. Save the Free Readiness Scan for the next paper you have not submitted yet.
Guidance first. Use the scan for the next manuscript.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- The Lancet 'Under Review': Status Meanings, Timelines, and What to Expect
- The Lancet Submission Process: Steps & Timeline
- How to Avoid Desk Rejection at The Lancet
- The Lancet Acceptance Rate 2026: Stats and What They Mean
- Lancet Impact Factor 2026: 88.5, Rank 1/332, and What It Means
- Is The Lancet a Good Journal? Fit Verdict
Supporting reads
Conversion step
Use this page to interpret the status and choose the next sensible move.
Guidance first. Use the scan for the next manuscript.